Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Epizyme Inc (EPZM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Epizyme Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Epizyme Inc historical data, for real-time data please try another search
1.470 0.000    0.00%
11/08 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.470 - 1.500
Epizyme Inc 1.470 0.000 0.00%

EPZM Balance Sheet

 
Featured here, the Balance Sheet for Epizyme Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/06
2022
31/03
2021
31/12
2021
30/09
Total Current Assets - 228.71 206.04 247.6
Cash and Short Term Investments - 199.73 176.79 221.29
Cash - - - -
Cash & Equivalents - 77.42 98.34 124.52
Short Term Investments - 122.31 78.45 96.78
Total Receivables, Net - 5.9 6.57 3.33
Accounts Receivables - Trade, Net - 5.9 6.57 3.33
Total Inventory - 4.59 3.22 1.52
Prepaid Expenses - 18.48 19.46 21.45
Other Current Assets, Total - - - -
Total Assets - 312.19 289 332.27
Property/Plant/Equipment, Total - Net - 20.58 21.6 22.88
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 40.77 41.81 42.85 43.89
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 21.09 18.51 17.9
Other Assets, Total 67.68 - - -
Total Current Liabilities - 38.97 45.2 44.73
Accounts Payable - 7.91 10.27 9.86
Payable/Accrued - - - -
Accrued Expenses - 31.06 34.93 34.87
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total - - - -
Total Liabilities - 301.06 309.69 316.89
Total Long Term Debt - 232.49 232.12 231.84
Long Term Debt - 232.49 232.12 231.84
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -203.42 29.6 32.38 40.32
Total Equity - 11.12 -20.69 15.38
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - 36.13 36.13 36.13
Common Stock, Total - 0.02 0.01 0.01
Additional Paid-In Capital - 1270.51 1183.01 1168.43
Retained Earnings (Accumulated Deficit) - -1295.34 -1239.84 -1189.18
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - -0.19 - -0
Total Liabilities & Shareholders' Equity - 312.19 289 332.27
Total Common Shares Outstanding 168.36 164.87 106.1 103.66
Total Preferred Shares Outstanding - 0.34 0.34 0.34
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EPZM Comments

Write your thoughts about Epizyme Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Thao Bui
Thao Bui Mar 01, 2022 8:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
OKE, shjt , continue waiting
Chris Helm
Chris Helm Feb 09, 2022 5:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.fiercebiotech.com/biotech/gsk-kills-one-barron-s-early-darlings-axing-two-synthetic-lethal-programs-and-epizyme-pact
Chris Helm
Chris Helm Feb 01, 2022 11:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do you think? Back to 12usd in a year?
Chris Helm
Chris Helm Feb 01, 2022 11:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Copy from Yahoo Finance......interesting.....Does anyone remember what SAVA did last year? It literally dropped to dollar range and shot up over $60 a share over night! All cancer drugs went for a rise with their uptrend. This is a great spot to be in if you can purchase in this range and hold. I could see this creating a lot of millionaires.
Thao Bui
Thao Bui Nov 30, 2021 10:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
waiting news and bullish
Binh Nguyen
Binh Nguyen Dec 09, 2020 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Medium target $22.50, high estimate $36. I like the odd 👍👍
Thao Bui
Thao Bui Dec 09, 2020 11:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
and now is 6, do you want buy more?
Madkam Bheema
Madkam Bheema Nov 07, 2020 7:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice terending
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email